Progress of triazole antifungal agent posaconazole in individualized therapy
Journal of Clinical Pharmacy and Therapeutics · 2022-12 · 47 (12) · 1966-1981
DOI: 10.1111/jcpt.13821 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Pharmacy and Therapeutics, online erschienen am 03.12.2022. Verfasst von Yishuo Shu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Shando…. Hauptthemen laut MEDLINE: Antifungal Agents, Triazoles. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 103 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Pharmacy, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Shandong Engineering and Technology Research Center for Pediatric Drug Devel…
ORCID-Profile: Yishuo Shu, Yinping Shi, Yilei Yang, Qiaoyan Yi, Haiyan Shi
Zitieren
APA
Shu, Y., Shi, Y., Yang, Y., Dong, Z., Yi, Q., & Shi, H. (2022). Progress of triazole antifungal agent posaconazole in individualized therapy. Journal of Clinical Pharmacy and Therapeutics, 47(12), 1966-1981. https://doi.org/10.1111/jcpt.13821
Vancouver
Shu Y, Shi Y, Yang Y, Dong Z, Yi Q, Shi H. Progress of triazole antifungal agent posaconazole in individualized therapy. Journal of Clinical Pharmacy and Therapeutics. 2022;47(12):1966-1981. doi:10.1111/jcpt.13821
BibTeX
@article{Shu2022,
author = {Shu, Yishuo and Shi, Yinping and Yang, Yilei and Dong, Zhonghua and Yi, Qiaoyan and Shi, Haiyan},
title = {Progress of triazole antifungal agent posaconazole in individualized therapy},
journal = {Journal of Clinical Pharmacy and Therapeutics},
year = {2022},
volume = {47},
number = {12},
pages = {1966--1981},
doi = {10.1111/jcpt.13821}
}
EUVIMED